EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5.17 Cr | ₹-13 Cr | ₹-16 Cr | ₹-17 Cr | ₹-12 Cr |
What is the latest Cash Flow from Investing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5.17 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Investing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.17 Cr | Negative | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹260.6 Cr | 1.2% | -2.5% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,997.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,804.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 1.2% |
-2.5% |
-13% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses